BACKGROUND AND OBJECTIVES: KCNH5 encodes the voltage-gated potassium channel EAG2/Kv10.2. We aimed to delineate the neurodevelopmental and epilepsy phenotypic spectrum associated with de novo KCNH5 variants. METHODS: We screened 893 individuals with developmental and epileptic encephalopathies for KCNH5 variants using targeted or exome sequencing. Additional individuals with KCNH5 variants were identified through an international collaboration. Clinical history, EEG, and imaging data were analyzed; seizure types and epilepsy syndromes were classified. We included 3 previously published individuals including additional phenotypic details. RESULTS: We report a cohort of 17 patients, including 9 with a recurrent de novo missense variant p.Arg327His, 4 with a recurrent missense variant p.Arg333His, and 4 additional novel missense variants. All variants were located in or near the functionally critical voltage-sensing or pore domains, absent in the general population, and classified as pathogenic or likely pathogenic using the American College of Medical Genetics and Genomics criteria. All individuals presented with epilepsy with a median seizure onset at 6 months. They had a wide range of seizure types, including focal and generalized seizures. Cognitive outcomes ranged from normal intellect to profound impairment. Individuals with the recurrent p.Arg333His variant had a self-limited drug-responsive focal or generalized epilepsy and normal intellect, whereas the recurrent p.Arg327His variant was associated with infantile-onset DEE. Two individuals with variants in the pore domain were more severely affected, with a neonatal-onset movement disorder, early-infantile DEE, profound disability, and childhood death. DISCUSSION: We describe a cohort of 17 individuals with pathogenic or likely pathogenic missense variants in the voltage-sensing and pore domains of Kv10.2, including 14 previously unreported individuals. We present evidence for a putative emerging genotype-phenotype correlation with a spectrum of epilepsy and cognitive outcomes. Overall, we expand the role of EAG proteins in human disease and establish KCNH5 as implicated in a spectrum of neurodevelopmental disorders and epilepsy.

*These authors contributed equally as first authors

†These authors contributed equally as senior authors

From the Ken and Ruth Davee Department of Neurology Northwestern University Feinberg School of Medicine Chicago IL

See more in PubMed

Bauer CK, Schwarz JR. Ether-a-go-go K(+) channels: effective modulators of neuronal excitability. J Physiol. 2018;596(5):769-783. doi: 10.1113/jp275477 PubMed DOI PMC

Simons C, Rash LD, Crawford J, et al. . Mutations in the voltage-gated potassium channel gene KCNH1 cause Temple-Baraitser syndrome and epilepsy. Nat Genet. 2015;47(1):73-77. doi: 10.1038/ng.3153 PubMed DOI

Kortum F, Caputo V, Bauer CK, et al. . Mutations in KCNH1 and ATP6V1B2 cause Zimmermann-Laband syndrome. Nat Genet. 2015;47(6):661-667. doi: 10.1038/ng.3282 PubMed DOI

Gripp KW, Smithson SF, Scurr IJ, et al. . Syndromic disorders caused by gain-of-function variants in KCNH1, KCNK4, and KCNN3-a subgroup of K(+) channelopathies. Eur J Hum Genet. 2021;29(9):1384-1395. doi: 10.1038/s41431-021-00818-9 PubMed DOI PMC

Mastrangelo M, Scheffer IE, Bramswig NC, et al. . Epilepsy in KCNH1-related syndromes. Epileptic Disord. 2016;18(2):123-136. doi: 10.1684/epd.2016.0830 PubMed DOI

Veeramah KR, Johnstone L, Karafet TM, et al. . Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia. 2013;54(7):1270-1281. doi: 10.1111/epi.12201 PubMed DOI PMC

Minardi R, Licchetta L, Baroni MC, et al. . Whole-exome sequencing in adult patients with developmental and epileptic encephalopathy: it is never too late. Clin Genet. 2020;98(5):477-485. doi: 10.1111/cge.13823 PubMed DOI

Imafidon ME, Sikkema-Raddatz B, Abbott KM, et al. . Strategies in rapid genetic diagnostics of critically Ill children: experiences from a Dutch university hospital. Front Pediatr. 2021;9:600556. doi: 10.3389/fped.2021.600556 PubMed DOI PMC

Saganich MJ, de Miera EVS, Nadal MS, Baker H, Coetzee WA, Rudy B. Cloning of components of a novel subthreshold-activating K(+) channel with a unique pattern of expression in the cerebral cortex. J Neurosci. 1999;19(24):10789-10802. doi: 10.1523/jneurosci.19-24-10789.1999 PubMed DOI PMC

Jeng CJ, Chang CC, Tang CY. Differential localization of rat Eag1 and Eag2 K+ channels in hippocampal neurons. Neuroreport 2005;16(3):229-233. doi: 10.1097/00001756-200502280-00005 PubMed DOI

Yang Y, Vasylyev DV, Dib-Hajj F, et al. . Multistate structural modeling and voltage-clamp analysis of epilepsy/autism mutation Kv10.2-R327H demonstrate the role of this residue in stabilizing the channel closed state. J Neurosci. 33(42);2013:16586-16593. doi: 10.1523/jneurosci.2307-13.2013 PubMed DOI PMC

Scheffer IE, Berkovic S, Capovilla G, et al. . ILAE classification of the epilepsies: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):512-521. doi: 10.1111/epi.13709 PubMed DOI PMC

Fisher RS, Cross JH, French JA, et al. . Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):522-530. doi: 10.1111/epi.13670 PubMed DOI

Carvill GL, Heavin SB, Yendle SC, et al. . Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet. 2013;45(7):825-830. doi: 10.1038/ng.2646 PubMed DOI PMC

Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36(10):928-930. doi: 10.1002/humu.22844 PubMed DOI PMC

Epi25, Collaborative Electronic address sberkovic@unimelbeduau, Epi25 Collaborative. Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals. Am J Hum Genet. 2019;105(2):267-282. doi: 10.1016/j.ajhg.2019.05.020 PubMed DOI PMC

gnomAD [online]. Available at: gnomad.broadinstitute.org

TopMED [online]. Available at: bravo.sph.umich.edu/freeze3a/hg19/

Richards S, Aziz N, Bale S, et al. . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405-424. doi: 10.1038/gim.2015.30 PubMed DOI PMC

Pettersen EF, Goddard TD, Huang CC, et al. . UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30(1):70-82. doi: 10.1002/pro.3943 PubMed DOI PMC

Rentzsch P, Schubach M, Shendure J, Kircher M. CADD-Splice-improving genome-wide variant effect prediction using deep learning-derived splice scores. Genome Med. 2021;13(1):31. doi: 10.1186/s13073-021-00835-9 PubMed DOI PMC

McTague A, Howell KB, Cross JH, Kurian MA, Scheffer IE. The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol. 2016;15(3):304-316. doi: 10.1016/s1474-4422(15)00250-1 PubMed DOI

Barcia G, Fleming MR, Deligniere A, et al. . De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet. 2012;44(11):1255-1259. doi: 10.1038/ng.2441 PubMed DOI PMC

Ambrosino P, Soldovieri MV, Bast T, et al. . De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy. Ann Neurol. 2018;83(6):1198-1204. doi: 10.1002/ana.25248 PubMed DOI

Miceli F, Soldovieri MV, Ambrosino P, et al. . Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits. J Neurosci. 2015;35(9):3782-3793. doi: 10.1523/jneurosci.4423-14.2015 PubMed DOI PMC

Torkamani A, Bersell K, Jorge BS, et al. . De novo KCNB1 mutations in epileptic encephalopathy. Ann Neurol. 2014;76(4):529-540. doi: 10.1002/ana.24263 PubMed DOI PMC

Syrbe S, Hedrich UBS, Riesch E, et al. . De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy. Nat Genet. 2015;47(4):393-399. doi: 10.1038/ng.3239 PubMed DOI PMC

Niday Z, Tzingounis AV. Potassium Channel gain of function in epilepsy: an unresolved paradox. Neuroscientist. 2018;24(4):368-380. doi: 10.1177/1073858418763752 PubMed DOI PMC

Karczewski KJ, Francioli LC, Tiao G, et al. . The mutational constraint spectrum quantified from variation in 141, 456 humans. Nature. 2020;581(7809):434-443. doi: 10.1038/s41586-020-2308-7 PubMed DOI PMC

Hamilton MJ, Suri M. “Electrifying dysmorphology”: potassium channelopathies causing dysmorphic syndromes. Adv Genet. 2020;105:137-174. doi: 10.1016/bs.adgen.2020.03.002 PubMed DOI

Aubert Mucca M, Patat O, Whalen S, et al. . Patients with KCNH1-related intellectual disability without distinctive features of Zimmermann-Laband/Temple-Baraitser syndrome. J Med Genet. 2021;59(5):505-510. doi: 10.1136/jmedgenet-2020-107511 PubMed DOI

Fukai R, Saitsu H, Tsurusaki Y, et al. . De novo KCNH1 mutations in four patients with syndromic developmental delay, hypotonia and seizures. J Hum Genet. 2016;61(5):381-387. doi: 10.1038/jhg.2016.1 PubMed DOI

The Human Protein Atlas. Updated December 7, 2022. proteinatlas.org/

GTEx Portal. gtexportal.org/home/

Omasits U, Ahrens CH, Muller S, Wollscheid B. Protter: interactive protein feature visualization and integration with experimental proteomic data. Bioinformatics. 2014;30(6):884-886. doi: 10.1093/bioinformatics/btt607 PubMed DOI

Silk M, Petrovski S, Ascher DB. MTR-Viewer: identifying regions within genes under purifying selection. Nucleic Acids Res. 2019;47(W1):W121–W126. doi: 10.1093/nar/gkz457 PubMed DOI PMC